Graph Representation Learning for Predictive Drug Discovery: A Molecular Graph Neural Network (MGNN) Approach i

Predictive drug discovery has turned out
as an important strategy to expedite the process of
identifying biologically active substances with little time
and cost involved in pharmaceutical development. This
paper uses deep learning methods based on graphs to
further advance the ability of predicting molecular
activity by encoding chemical structures as a graph
instead of the conventional descriptors. The model was
trained and evaluated on the DOROTHEA Drug
Discovery dataset which was retrieved on Kaggle and
comprised of around 100,000 compounds that were
classified as active or inactive. The framework of a
Molecular Graph Neural Network (MGNN) was created
based on which the passing of messages between atoms
(nodes) and bonds (edges) can be performed to capture
the complex dependencies within molecular graphs. The
strategy combines both atomic and bond-level details by
successive iterations of messages, after which it then graph
provides pooling and dense layers of classification to
predict activities. The study demonstrated that the MGNN
developed is characterized by a high accuracy of 96% and
AUC of 0.995, which is significantly higher than other
traditional models, such as the Random Forest, SVM, and
CNN based descriptor models. Besides, the model is highly
interpretable and cross-molecularly generalized. The main
value of this study is that it shows that graph
representation learning can be useful in predictive drug
discovery and provides a scalable and interpretable model
of reliable predictability of compound activity and data�driven pharmaceutical innovation.